An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients
Opass Putcharoen,1–3 Stephen J Kerr,4 Kiat Ruxrungtham2,4,5 1Division of Infectious Diseases, Department of Medicine, Chulalongkorn University, 2Faculty of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Chulalongkorn University, 3Center of Excellence for Infectious...
Saved in:
Main Authors: | Putcharoen O, Kerr SJ, Ruxrungtham K |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/ec33a39843224dbd9b05ab35b8bbfda7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimizing management of treatment-naïve and treatment-experienced HIV+ patients: the role of maraviroc
by: Eva Poveda, et al.
Published: (2010) -
Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility of a single tablet of emtricitabine, rilpivirine, and tenofovir
by: Wainberg MA
Published: (2013) -
Dolutegravir/rilpivirine for the treatment of HIV-1 infection
by: Dowers E, et al.
Published: (2018) -
Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans
by: Nanzigu S, et al.
Published: (2013) -
New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir
by: Patel N, et al.
Published: (2012)